Bankruptcy court clears Purdue to fund low-cost opioid rescue medication

A bankruptcy court has boosted Harm Reduction Therapeutics’ (HRT) bid to develop a low-cost opioid rescue medication. With the court handling Purdue Pharma’s case approving the transfer of cash to HRT, the nonprofit drug developer is set to receive up to $11 million.